Advanced search

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
De Rycke, Leen, Dominique Baeten, Filip Van Den Bosch, Herman Mielants, Filip De Keyser, and Eric Veys. 2004. “The Effect of Infliximab on Skin Lesions in a Patient with Scleroderma (CREST).” In Arthritis Research & Therapy, 6:31. BIOMED CENTRAL LTD.
APA
De Rycke, Leen, Baeten, D., Van Den Bosch, F., Mielants, H., De Keyser, F., & Veys, E. (2004). The effect of infliximab on skin lesions in a patient with scleroderma (CREST). ARTHRITIS RESEARCH & THERAPY (Vol. 6, p. 31). BIOMED CENTRAL LTD.
Vancouver
1.
De Rycke L, Baeten D, Van Den Bosch F, Mielants H, De Keyser F, Veys E. The effect of infliximab on skin lesions in a patient with scleroderma (CREST). ARTHRITIS RESEARCH & THERAPY. BIOMED CENTRAL LTD; 2004. p. 31.
MLA
De Rycke, Leen, Dominique Baeten, Filip Van Den Bosch, et al. “The Effect of Infliximab on Skin Lesions in a Patient with Scleroderma (CREST).” Arthritis Research & Therapy. Vol. 6. BIOMED CENTRAL LTD, 2004. 31. Print.
@inproceedings{305710,
  author       = {De Rycke, Leen and Baeten, Dominique and Van Den Bosch, Filip and Mielants, Herman and De Keyser, Filip and Veys, Eric},
  booktitle    = {ARTHRITIS RESEARCH \& THERAPY},
  issn         = {1478-6362},
  language     = {eng},
  pages        = {S31-S31},
  publisher    = {BIOMED CENTRAL LTD},
  title        = {The effect of infliximab on skin lesions in a patient with scleroderma (CREST)},
  volume       = {6},
  year         = {2004},
}

Web of Science
Times cited: